Internal QC Programs a quantitative approach - PowerPoint PPT Presentation

1 / 43
About This Presentation
Title:

Internal QC Programs a quantitative approach

Description:

Levy-Jennings Plots. When in control: Centered around Mean. Only outside 2SD 5% Outside 3SD 1 ... Based on Levy-Jennings plots ' ... – PowerPoint PPT presentation

Number of Views:371
Avg rating:3.0/5.0
Slides: 44
Provided by: graham137
Category:

less

Transcript and Presenter's Notes

Title: Internal QC Programs a quantitative approach


1
Internal QC Programs- a quantitative approach
  • Graham Jones
  • Chemical Pathology

2
Quality Terminology
  • QA - Quality Assurance
  • Planned, systematic actions providing confidence
    that a quality output will be produced
  • Laboratory Procedures
  • IQC - Internal Quality Control (QC)
  • Procedures use to assess validity of results in
    real time, controls release of results
  • QC material run with patient samples
  • EQA - External Quality Assessment
  • Procedures operated by an external agency which
    allow retrospective review of performance
  • RCPA-AACB

3
Internal QA
  • An Internal Quality Assurance (IQA) program is a
    tool to assist with maintenance of correlation
    between different analysers in the same
    laboratory.
  • Our IQA program includes the following features
  • frequent sample distributions (2-3 pairs per
    week)
  • the use of patient samples to reduce matrix
    effects
  • unknown values at the time of measurement
  • a range of values to cover the measurement range
  • result review occurring at some stage after
    analysis
  • We have developed a spreadsheet application to
    allow user friendly review of results.

4
QC Issues
  • Selection of material (matrix)
  • Selection of levels (decision points)
  • Setting of targets and ranges
  • Decision on frequency (batch vs RA)
  • Decision on number of QC samples (n)
  • Response to out-of-range values
  • Quality planning

5
What is the aim of QC?
  • To ensure that results released are OK
  • To identify when the assay is not performing
    satisfactorily
  • Question
  • How good do we need to be to be OK?

6
QC Variables
  • Batch assays
  • With run
  • Accept or reject whole batch
  • Random Access
  • Hold results, run QC, then release results
  • Run and release results, run QC
  • If QC fails, may need to re-run previous results.

7
QC Design
  • Bench Level
  • Simple, reproducible procedure to ascertain
    acceptability of current functioning.
  • Knowledge of basic procedures to correct problems
  • Supervisor Level
  • Knowledge of whole Quality Assurance
  • Link effects of QC to patient results
  • Set up and administer system

8
What does a result mean
  • A single result means that the actual value has a
    95 chance of lying within /- 2SD of that result
    (SD of assay at that level)
  • Performing replicates narrows the range within
    which the actual value is likely to lie.
    (Standard error of the mean, SD/vn)
  • Applies to QC as well as patient samples

SEM
/- 2SD
9
Levy-Jennings Plots
3SD
  • When in control
  • Centered around Mean
  • Only outside 2SD 5
  • Outside 3SD lt1

2SD
Mean
-2SD
-3SD
TIME
10
Levy-Jennings Plots
3SD
2SD
Mean
-2SD
Shift in Mean
-3SD
Shift in SD
11
Assay failure
  • Assay change by
  • Change in Mean (A)
  • Change in SD (B)
  • Blunders
  • Usual QC programs best at detecting shifts in
    mean

A
B
12
Interpreting Results
  • One result 2 SD from the mean

3SD
2SD
Mean
-2SD
-3SD
13
QC results - Examples
  • A QC result at 2 SD of assay performance
  • 5 chance that the result reflects normal assay
    performance
  • 50 chance that true result (mean) is above
    that value (ie assay has changed by gt2SD)

14
QC results - Examples
  • A QC result at 10SD of assay performance
  • 0 chance that the result reflects normal assay
    performance
  • 100 chance that true result represents change
    in assay mean (ie assay mean has changed by gt7 SD)

15
QC - improving power to detect changes
  • To improve the probability of detecting a change
    assay performance
  • one QC further from the mean (eg gt3SD)
  • see more QC values gt2SD
  • Principle Certainty of a true change is
    increased by
  • A result further from the mean
  • More results showing the same deviation

16
Being sure that the assay has changed
  • Many results a bit different
  • One result very different

3SD
2SD
Mean
-2SD
-3SD
17
Multi-rules
  • Looks at many results
  • eg
  • 1 x 3S (one value gt3SD from mean)
  • 2 x 2S (2 values gt2 SD from mean)
  • 4 x 1S (4 values gt1 SD from mean)
  • All may indicate a significant shift in the assay
    mean
  • Increases chance of finding an error.

18
Summary thus far
  • Big Shifts
  • Easy to detect
  • High probability of detection
  • Can use simple rules with few QC samples
  • Little shifts
  • Hard to detect
  • Low probability of detection
  • Use multi-rules with many QC samples
  • Hard to detect shifts of less than 2.5 SD

19
Westgard - Quantifying QC
  • Process of quantifying power of QC to detect
    changes
  • Based on Levy-Jennings plots
  • If the mean shifts by X, what chance is there
    that my QC process will detect the change
  • or
  • With my current QC process, what changes can I
    reliably detect

20
Terminology
  • n - number of QC samples run together
  • (commonly n2 for Chemistry, often n3 for
    Immunoassays)
  • 1 3s - 1 QC result gt3 SD from the mean
  • 2 2s - 2 QC results gt2 SD from mean
  • 4 1s - 4 QC results gt 1 SD from mean
  • Multi-rules can be within run (across material)
    or same material (across runs)
  • 3of4 1s - 3 out of 4 gt1 SD from mean

21
Original Westgard Multi-rules
22
www.westgard.com/
23
Westgard - QC Quantitation
3SD
2SD
Mean
-2SD
-3SD
24
Power Function Graphs
P- ED
P- FR
25
Power Function Graphs
P- ED
P- FR
26
Power Function Graph (n2)
12s
12.5s
MR
13.5s
27
Power Function Charts (1 3s)
n8
n4
n1
28
Power Function Charts - Summary
  • Allows quantitation of assay shifts which can be
    detected for various QC protocols
  • Variables
  • n, rules
  • Shows probability of detecting change
  • Can allow choice of QC protocols to detect
    certain errors

29
Shifts and Results
  • An assay may produce results up to 2SD from the
    true value when working well.
  • If the mean shifts by 2 SD, results may be
    produced up to 4 SD from the true value
  • If we can detect a shift of 3SD 90 of the time,
    then when undetected, a 5SD error may be released
    2.5 of the time

2SD
30
QC Goals
  • Do we want to identify statistically significant
    changes in assay performance?
  • or
  • Do we want to measure clinically important
    changes in assay performance?
  • Eg is a 2 change in an amylase result worth
    fixing!

31
SydPath QC Protocol
  • 4) Interpretation
  • In response to the QC results, one of three
    options can be chosen
  • 1. CONTINUE - continue without change
  • 2. PAUSE - Stop releasing results -
    troubleshoot assay and continue when fixed
  • 3. STOP - Stop releasing results - troubleshoot
    assay, rerun previous samples if assay changed
    (Re-run not required when problem is shown to be
    due to QC material).

32
SydPath QC Protocol
  • If both QC in Range (lt2LSD) CONTINUE
  • If either (of 2) QC ? 3LSD STOP
  • If 2 (of 2, High and Low) QC ? L2SD STOP
  • If 1 (of 2) QC ? 2LSD and lt3LSD - stop releasing
    results, repeat High and Low QC for that analyte
  • If, of the repeat QC results
  • Either QC ? 3LSD STOP
  • Both QC ? 2LSD STOP
  • Either QC ? 2LSD PAUSE
  • Otherwise CONTINUE
  • These rules have the power to cause a STOP 90 of
    the occasions when there is a shift in the assay
    of 2.8 x LSD and cause a PAUSE 90 of the
    occasions when there is a shift in the assay of
    2.6 x LSD.

33
SydPath QC
  • Rerun Protocol
  • Choose 5-10 previous samples measured since the
    previous in-control QC.
  • Re-analyse once assay fixed.
  • Compare original results and change in computer
    if results significantly different.
  • If all samples re-run are different, re-run
    earlier samples until correct results obtained.
  • Decisions about significant differences to be
    based on CAL Re-Run Protocol . Refer to CAL
    Result Change Assessment Chart (based on
    RCPA-AACP EQA Allowable Limits of Performance).
  • If a change is required to a previously released
    result which may have been seen by a clinician
    1) Inform the requesting Doctor of any
    clinically significant change of results.
  • 2) Enter the new result in place of the
    previous result and insert the following
    footnote
  • "AAAAA Following re-analysis, result changed
    from previously reported value of BBB at CCCC
    on DD/DD/DD. EEEE informed of change in result."

34
Change Protocol
In the event of re-running an assay following the
suspicion of an analytical error, significant
changes must be changed in the computer and
notified to the requesting/treating doctor.
Changes equal to, or greater than those shown
below may be considered significant (these values
based on the RCPA-AACB Allowable limits of
performance). If in doubt, consult the
Pathologist or Senior Scientist.
35
The Reverse Process - Capability
  • Identify Analytical Goals
  • Agreed clinical targets
  • RCPA-AACB Allowable Limits of Performance (ALP)
  • CLIA targets
  • Set up a QC program which has a high probability
    of detecting an error this size together with a
    low false-rejection rate.

36
Capability - Quantitative Tests
/- 2 SD
  • Actual variation compared to
  • clinically required variation
  • SD of QC material compared
  • to Allowable Limits of
  • Performance (ALP)
  • CpALP/SD

/- ALP
37
Capability
Cp 6
2.5 SD Shift
2 SD spread
Cp 4
Cp 3
ALP
38
Capability
  • Good assays (capable) have an analytical
    performance (SD) which is much less than the
    clinically important change.
  • This can be quantified as the Capability index
    CpALP/SD
  • (ALPAllowable limit of Performance)
  • gt6 great
  • 4-6 OK
  • lt4 poor

39
Capability in practice
  • Capable assays can use different QC to less
    capable assays
  • Eg
  • Simpler rules
  • Less QC runs
  • Can also set tighter limits to correct a true
    change in the assay performance before it is bad
    enough to stop releasing results.

40
Capability
  • Assays may be poor because of
  • The laboratory
  • The method
  • The industry
  • If
  • Lab trouble-shoot
  • Method consider changing method
  • Industry wait!

41
Setting Ranges for QC
  • Actual SDs are difficult to determine exactly
    (which results to exclude)
  • Actual SDs change over time
  • But need to put limits into instruments as mean
    /- 2SD to fixed sig figs
  • Suggest
  • Actual SD (ASD, measured SD)
  • Limit SD (LSD, put into QC package)

42
Chemical Pathology
  • Run-in new QC for urine and serum
  • Set target ranges
  • Assess power to detect errors of current process
  • Future
  • Review performance
  • Target poor assays
  • adjust n, rules, frequency

43
Summary
  • Some aspects of QC can be quantified
  • This process allows us to use appropriate QC
  • can either
  • Know how good we are
  • or
  • Aim to reach certain targets
Write a Comment
User Comments (0)
About PowerShow.com